Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Vandana Singh

4606 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

Rising Cost For Health Insurers Bites CVS Health’s Q1 Profit, Stock Tanks

By Vandana Singh
May 1, 8:52 AM
CVS Health Q1 sales of $88.4 billion, up 3.7% Y/Y. Adjusted EPS at $1.31, down from $2.20. Health Care Benefits segment sees strong growth, while Health Services segment faces challenges. Revised 2024 guidance reflects continued pressure on earnings.

CVS

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • Earnings
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs

By Vandana Singh
April 30, 3:11 PM
Eli Lilly boosts production for obesity and diabetes drugs, reports mixed Q1 results. Expectations for supply growth in 2024 outlined. Insights into payor access and reimbursement strategies discussed.

LLY

Read More
2 minute read
  • General
  • Health Care
  • Large Cap
  • News

Walmart to Shut Down All Clinic Locations Amid Rising Costs – What It Means for Your Healthcare?

By Vandana Singh
April 30, 1:17 PM
Walmart to close healthcare clinics nationwide. 51 clinic locations shutting down, pharmacies and vision centers remain open. Company cites challenging reimbursement environment and rising operating costs.

WMT

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News
  • Top Stories

Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab

By Vandana Singh
April 30, 11:54 AM
Sandoz resolves patent litigation with Amgen, paving the way for the launch of denosumab biosimilars Jubbonti and Wyost.

AMGN

Read More
2 minute read
  • Movers

Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study

By Vandana Singh
April 30, 11:46 AM
NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression.

NRXP

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • M&A
  • Movers
  • News
  • Top Stories

Harmony Biosciences Expands It CNS-Focused Pipeline With Epilepsy Candidate, Q1 Earnings Beat Street View

By Vandana Singh
April 30, 11:44 AM
Harmony Biosciences expands its late-stage CNS pipeline with the acquisition of Epygenix Therapeutics, bolstering its rare epilepsy offerings. Harmony's Q1 performance shows robust growth, with adjusted EPS surpassing expectations.

HRMY

Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

GE HealthCare’s Q1 Earnings Miss Wall Street Projections, But It Sticks To Annual Guidance

By Vandana Singh
April 30, 11:31 AM
GE Healthcare reports first-quarter sales of $4.6 billion, with net income of $374 million. Imaging and ultrasound segment revenues down, but pharmaceutical diagnostics up. Despite challenges in China, CEO remains optimistic, reaffirming guidance for 2024.

GEHC

Read More
2 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

Why Is Hospital Chain Operator Tenet Healthcare Stock Soaring On Tuesday?

By Vandana Singh
April 30, 10:53 AM
Discover Tenet Healthcare's robust first-quarter performance, boasting $5.37 billion in sales, a 7% Y/Y increase. With strong revenue growth, admissions, and profitability, Tenet is raising its fiscal year 2024 revenue guidance to $20-$20.4 billion.

THC

Read More
2 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News
  • Top Stories

Eli Lilly’s Weight-Loss Drug Still Going Strong, Boosts Annual Forecast

By Vandana Singh
April 30, 9:41 AM
"Eli Lilly & Co's Q1 2024: Revenue hits $8.8 billion, up 26% Y/Y, driven by volume & higher prices. Strong demand for key drugs like Mounjaro & Verzenio. EPS beats at $2.58. FY24 guidance raised to $42.4 billion-$43.6 billion, citing robust performance.

LLY

Read More
1 minute read
  • Exclusives
  • Fintech
  • General
  • Market-Moving Exclusives
  • News
  • Real Estate

EXCLUSIVE: AI-Enabled Real Estate Platform Janover Officially Launches Insurtech Subsidiary

By Vandana Singh
April 30, 8:15 AM
Janover unveils Janover Insurance Group Inc, its new insurtech subsidiary specializing in commercial property insurance. With licenses secured in Texas and Florida and expansions underway, Janover aims for national coverage.

JNVR

Posts pagination

Previous 1 … 27 28 29 … 461 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service